His primary areas of study are Internal medicine, Surgery, Orthostatic vital signs, Anesthesia and Diabetes mellitus. His Internal medicine research incorporates themes from Diabetic neuropathy, Endocrinology, Gastroenterology and Cardiology. His research in Surgery tackles topics such as Epidemiology which are related to areas like Incidence.
Within one scientific family, he focuses on topics pertaining to Physical therapy under Orthostatic vital signs, and may sometimes address concerns connected to Autonomic disorder. He has included themes like Muscle weakness, Droxidopa and Pyridostigmine in his Anesthesia study. His study in Diabetes mellitus is interdisciplinary in nature, drawing from both Placebo and Lipoic acid.
His scientific interests lie mostly in Internal medicine, Anesthesia, Endocrinology, Cardiology and Orthostatic vital signs. The Internal medicine study combines topics in areas such as Diabetes mellitus and Gastroenterology. His Diabetes mellitus research focuses on Surgery and how it connects with Placebo.
His Anesthesia research integrates issues from Blood pressure and Heart rate. His Endocrinology research is multidisciplinary, relying on both Sciatic nerve and Nerve conduction velocity. In his research on the topic of Pure autonomic failure, Neuroscience is strongly related with Autonomic nervous system.
Phillip A. Low spends much of his time researching Internal medicine, Atrophy, Orthostatic vital signs, Pure autonomic failure and Cardiology. The study incorporates disciplines such as Gastroenterology and Diabetes mellitus in addition to Internal medicine. His Diabetes mellitus research is multidisciplinary, incorporating perspectives in Surgery, Placebo and Insulin.
His Atrophy study incorporates themes from Dementia with Lewy bodies, Disease, Parkinsonism and Alpha-synuclein. His studies in Orthostatic vital signs integrate themes in fields like Anesthesia, Retrospective cohort study and Intensive care medicine. He has researched Pure autonomic failure in several fields, including Predictive value of tests, Autonomic nervous system, Autonomic reflex, Age of onset and Physical therapy.
Phillip A. Low mainly investigates Internal medicine, Atrophy, Pure autonomic failure, Cardiology and Dementia with Lewy bodies. Phillip A. Low interconnects Diabetes mellitus, Surgery and Gastroenterology in the investigation of issues within Internal medicine. His work carried out in the field of Atrophy brings together such families of science as Cerebellar ataxia, Neuroscience, Cohort study and Alpha-synuclein.
Phillip A. Low focuses mostly in the field of Neuroscience, narrowing it down to matters related to Dysautonomia and, in some cases, Anesthesia and Gastroparesis. His Pure autonomic failure research includes elements of Hazard ratio, Prospective cohort study, Age of onset, Autonomic nervous system and Physical therapy. The various areas that Phillip A. Low examines in his Cardiology study include Anhidrosis and Sudomotor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Second consensus statement on the diagnosis of multiple system atrophy
S. Gilman;G. K. Wenning;P. A. Low;D. J. Brooks.
Neurology (2008)
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome
Roy Freeman;Wouter Wieling;Felicia B. Axelrod;David G. Benditt.
Autonomic Neuroscience: Basic and Clinical (2011)
Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.
Roy Freeman;Wouter Wieling;Felicia B. Axelrod;David G. Benditt.
Clinical Autonomic Research (2011)
Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy
I. J. Schatz;R. Bannister;R. L. Freeman;C. G. Goetz.
Neurology (1996)
Consensus statement on the diagnosis of multiple system atrophy
S Gilman;P.A Low;N Quinn;A Albanese.
Journal of the Neurological Sciences (1999)
Oxidative stress in the pathogenesis of diabetic neuropathy.
Andrea M. Vincent;James W. Russell;Phillip Low;Eva L. Feldman.
Endocrine Reviews (2004)
Treatment of symptomatic diabetic polyneuropathy with the antioxidant α‐lipoic acid: a meta‐analysis
D. Ziegler;H. Nowak;P. Kempler;P. Vargha.
Diabetic Medicine (2004)
Oral Treatment With α-Lipoic Acid Improves Symptomatic Diabetic Polyneuropathy The SYDNEY 2 trial
Dan Ziegler;Alexander Ametov;Alexey Barinov;Peter J. Dyck.
Diabetes Care (2006)
Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
Vincenza Spallone;Dan Ziegler;Roy Freeman;Luciano Bernardi.
Diabetes-metabolism Research and Reviews (2011)
Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study
Paola Sandroni;Lisa M Benrud-Larson;Robyn L McClelland;Phillip A Low.
Pain (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Mayo Clinic
Mayo Clinic
Beth Israel Deaconess Medical Center
New York University
Mayo Clinic
Mayo Clinic
Mayo Clinic
Mayo Clinic
Vanderbilt University
University of Chicago
National University of Singapore
University at Buffalo, State University of New York
Stanford University
Northeastern University
University of Washington
Keio University
National Institutes of Health
Sapienza University of Rome
University of British Columbia
Chinese Academy of Sciences
Aix-Marseille University
University of Illinois at Urbana-Champaign
Tufts Medical Center
National Institutes of Health
Duke University